- Features
- Performances
- Specifications
- References
Autoimmune diseases (e.g., Systemic lupus erythematosus, Malignant rheumatoid arthritis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)
- Therapeutic plasmapheresis by removing pathogenic substances from patient's plasma by selective adsorption.
- No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
- Applicable to patients with protein allergy.
Trademark
IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.

IMMUSORBA PH
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.